Correlation Between Guidepath(r) Managed and Ridgeworth Ceredex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Guidepath(r) Managed and Ridgeworth Ceredex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guidepath(r) Managed and Ridgeworth Ceredex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guidepath Managed Futures and Ridgeworth Ceredex Small, you can compare the effects of market volatilities on Guidepath(r) Managed and Ridgeworth Ceredex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guidepath(r) Managed with a short position of Ridgeworth Ceredex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guidepath(r) Managed and Ridgeworth Ceredex.

Diversification Opportunities for Guidepath(r) Managed and Ridgeworth Ceredex

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Guidepath(r) and Ridgeworth is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Guidepath Managed Futures and Ridgeworth Ceredex Small in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ridgeworth Ceredex Small and Guidepath(r) Managed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guidepath Managed Futures are associated (or correlated) with Ridgeworth Ceredex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ridgeworth Ceredex Small has no effect on the direction of Guidepath(r) Managed i.e., Guidepath(r) Managed and Ridgeworth Ceredex go up and down completely randomly.

Pair Corralation between Guidepath(r) Managed and Ridgeworth Ceredex

Assuming the 90 days horizon Guidepath Managed Futures is expected to under-perform the Ridgeworth Ceredex. But the mutual fund apears to be less risky and, when comparing its historical volatility, Guidepath Managed Futures is 1.52 times less risky than Ridgeworth Ceredex. The mutual fund trades about -0.05 of its potential returns per unit of risk. The Ridgeworth Ceredex Small is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  689.00  in Ridgeworth Ceredex Small on September 3, 2024 and sell it today you would lose (60.00) from holding Ridgeworth Ceredex Small or give up 8.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Guidepath Managed Futures  vs.  Ridgeworth Ceredex Small

 Performance 
       Timeline  
Guidepath Managed Futures 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Guidepath Managed Futures has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Guidepath(r) Managed is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Ridgeworth Ceredex Small 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ridgeworth Ceredex Small are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Ridgeworth Ceredex may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Guidepath(r) Managed and Ridgeworth Ceredex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Guidepath(r) Managed and Ridgeworth Ceredex

The main advantage of trading using opposite Guidepath(r) Managed and Ridgeworth Ceredex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guidepath(r) Managed position performs unexpectedly, Ridgeworth Ceredex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ridgeworth Ceredex will offset losses from the drop in Ridgeworth Ceredex's long position.
The idea behind Guidepath Managed Futures and Ridgeworth Ceredex Small pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Correlations
Find global opportunities by holding instruments from different markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals